{"id":"NCT02964273","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)","officialTitle":"A Phase 3b, Two-part, Multicenter, One Year Randomized, Double-blind, Placebo-controlled Trial of the Safety, Pharmacokinetics, Tolerability, and Efficacy of Tolvaptan Followed by a Two Year Open-label Extension in Children and Adolescent Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-23","primaryCompletion":"2021-11-17","completion":"2021-11-17","firstPosted":"2016-11-16","resultsPosted":"2023-01-03","lastUpdate":"2023-01-03"},"enrollment":91,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Autosomal Dominant Polycystic Kidney Disease (ADPKD)"],"interventions":[{"type":"DRUG","name":"Tolvaptan","otherNames":["OPC-41061"]},{"type":"DRUG","name":"Tolvaptan Matching-placebo","otherNames":[]}],"arms":[{"label":"Phase A: Tolvaptan","type":"EXPERIMENTAL"},{"label":"Phase A: Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Phase B: Prior Tolvaptan","type":"EXPERIMENTAL"},{"label":"Phase B: Prior Placebo","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study is to assess the long term safety of treatment with tolvaptan in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD). The secondary objective is to assess the pharmacodynamics, pharmacokinetics, and efficacy of tolvaptan in the same participant population.","primaryOutcome":{"measure":"Phase A: Change From Baseline in Spot Urine Osmolality (Pre-morning Dose)","timeFrame":"Baseline, and Week 1 of Phase A","effectByArm":[{"arm":"Phase A: Tolvaptan","deltaMin":635,"sd":252},{"arm":"Phase A: Placebo","deltaMin":646,"sd":250}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":20,"countries":["Belgium","Germany","Italy","United Kingdom"]},"refs":{"pmids":["39356039","36719158","34604341"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":48},"commonTop":["Headache","Nasopharyngitis","Polyuria","Vomiting","Cough"]}}